Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington's disease.

Schroeder AM, Loh DH, Jordan MC, Roos KP, Colwell CS.

PLoS Curr. 2011 Nov 4;3:RRN1266. doi: 10.1371/currents.RRN1266.

2.

Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease.

Schroeder AM, Wang HB, Park S, Jordan MC, Gao F, Coppola G, Fishbein MC, Roos KP, Ghiani CA, Colwell CS.

PLoS One. 2016 Jan 25;11(1):e0147269. doi: 10.1371/journal.pone.0147269. eCollection 2016.

3.

Muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington's disease.

Valadão PA, de Aragão BC, Andrade JN, Magalhães-Gomes MP, Foureaux G, Joviano-Santos JV, Nogueira JC, Ribeiro FM, Tapia JC, Guatimosim C.

Eur J Neurosci. 2017 Mar;45(6):785-796. doi: 10.1111/ejn.13510. Epub 2017 Jan 30.

PMID:
27992085
4.

Cardiac Dysautonomia in Huntington's Disease.

Abildtrup M, Shattock M.

J Huntingtons Dis. 2013;2(3):251-61. doi: 10.3233/JHD-130054. Review.

PMID:
25062674
5.

Changes in structure and function of diaphragm neuromuscular junctions from BACHD mouse model for Huntington's disease.

de Aragão BC, Rodrigues HA, Valadão PA, Camargo W, Naves LA, Ribeiro FM, Guatimosim C.

Neurochem Int. 2016 Feb;93:64-72. doi: 10.1016/j.neuint.2015.12.013. Epub 2016 Jan 18.

PMID:
26796203
6.

Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.

Clemens LE, Weber JJ, Wlodkowski TT, Yu-Taeger L, Michaud M, Calaminus C, Eckert SH, Gaca J, Weiss A, Magg JC, Jansson EK, Eckert GP, Pichler BJ, Bordet T, Pruss RM, Riess O, Nguyen HP.

Brain. 2015 Dec;138(Pt 12):3632-53. doi: 10.1093/brain/awv290. Epub 2015 Oct 21.

PMID:
26490331
7.

Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6/2 and BACHD mouse models of Huntington's disease.

Miller S, Hill Della Puppa G, Reidling J, Marcora E, Thompson LM, Treanor J.

J Huntingtons Dis. 2014;3(4):333-41. doi: 10.3233/JHD-140129.

PMID:
25575954
8.

Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.

Farrar AM, Murphy CA, Paterson NE, Oakeshott S, He D, Alosio W, McConnell K, Menalled LB, Ramboz S, Park LC, Howland D, Brunner D.

J Huntingtons Dis. 2014;3(2):145-58. doi: 10.3233/JHD-130061.

PMID:
25062858
9.

Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.

Spampanato J, Gu X, Yang XW, Mody I.

Neuroscience. 2008 Dec 2;157(3):606-20. doi: 10.1016/j.neuroscience.2008.09.020. Epub 2008 Sep 18.

10.

Neurocardiovascular deficits in the Q175 mouse model of Huntington's disease.

Cutler TS, Park S, Loh DH, Jordan MC, Yokota T, Roos KP, Ghiani CA, Colwell CS.

Physiol Rep. 2017 Jun;5(11). pii: e13289. doi: 10.14814/phy2.13289.

11.

Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.

Rocher AB, Gubellini P, Merienne N, Boussicault L, Petit F, Gipchtein P, Jan C, Hantraye P, Brouillet E, Bonvento G.

Neurobiol Dis. 2016 Feb;86:131-9. doi: 10.1016/j.nbd.2015.10.016. Epub 2015 Nov 25.

PMID:
26626081
12.

Application of neurophysiological biomarkers for Huntington's disease: evaluating a phosphodiesterase 9A inhibitor.

Nagy D, Tingley FD 3rd, Stoiljkovic M, Hajós M.

Exp Neurol. 2015 Jan;263:122-31. doi: 10.1016/j.expneurol.2014.10.001. Epub 2014 Oct 12.

PMID:
25315303
13.

Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.

Hult Lundh S, Nilsson N, Soylu R, Kirik D, Petersén Å.

Hum Mol Genet. 2013 Sep 1;22(17):3485-97. doi: 10.1093/hmg/ddt203. Epub 2013 May 22.

PMID:
23697793
14.

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.

Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW.

J Neurosci. 2008 Jun 11;28(24):6182-95. doi: 10.1523/JNEUROSCI.0857-08.2008.

15.

Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's disease.

Abada YS, Schreiber R, Ellenbroek B.

Behav Brain Res. 2013 Feb 1;238:243-51. doi: 10.1016/j.bbr.2012.10.039. Epub 2012 Oct 30.

PMID:
23123142
16.

Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease.

Kudo T, Schroeder A, Loh DH, Kuljis D, Jordan MC, Roos KP, Colwell CS.

Exp Neurol. 2011 Mar;228(1):80-90. doi: 10.1016/j.expneurol.2010.12.011. Epub 2010 Dec 22.

17.

The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.

Doria JG, de Souza JM, Andrade JN, Rodrigues HA, Guimaraes IM, Carvalho TG, Guatimosim C, Dobransky T, Ribeiro FM.

Neurobiol Dis. 2015 Jan;73:163-73. doi: 10.1016/j.nbd.2014.08.021. Epub 2014 Aug 24.

PMID:
25160573
18.

Altered reactivity of central amygdala to GABAAR antagonist in the BACHD rat model of Huntington disease.

Lamirault C, Yu-Taeger L, Doyère V, Riess O, Nguyen HP, El Massioui N.

Neuropharmacology. 2017 Sep 1;123:136-147. doi: 10.1016/j.neuropharm.2017.05.032. Epub 2017 Jun 3.

PMID:
28587900
19.

Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington's disease.

Wood NI, Sawiak SJ, Buonincontri G, Niu Y, Kane AD, Carpenter TA, Giussani DA, Morton AJ.

J Huntingtons Dis. 2012;1(1):57-64. doi: 10.3233/JHD-2012-120004.

20.

Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington's Disease.

Wu BT, Chiang MC, Tasi CY, Kuo CH, Shyu WC, Kao CL, Huang CY, Lee SD.

Cardiovasc Toxicol. 2016 Apr;16(2):111-21. doi: 10.1007/s12012-015-9318-y.

PMID:
25800750

Supplemental Content

Support Center